Novacept

Novacept design, develop, manufacture & market innovative therapeutic devices to improve quality of women healthcare cost-effective manner.

Launch date

1995

Market cap

Enterprise valuation

€295m (Public information from Mar 2004)

Palo Alto California (HQ)

Date	Investors	Amount	Round
Mar 2002	New Enterprise Associates Three Arch Partners	$30.0m	Late VC
Mar 2004	Cytyc	$325m Valuation: $325m	Acquisition
Total Funding		€27.3m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Novacept